One year after an innovative building retrofit project, the Empire State Building is ahead of plan and has exceeded its year one energy-efficiency guarantee by five percent, saving $2.4 million and establishing a commercial real estate model for reducing costs, maximizing return on investment, increasing real estate value, and protecting the environment.
“First and foremost, making the Empire State Building energy efficient was a sound business decision that saved us millions of dollars in the first year,” said Anthony Malkin of the Empire State Building Company. “We have a proven model that shows building owners and operators how to cut costs and improve the value of their buildings by integrating energy efficiency into building upgrades.”
To view Multimedia News Release, go to http://www.multivu.com/players/English/55313-johnson-controls-empire-state-building-efficiency/
EXTNGO, 50 Feet CAT 6 Flat Retractable Network Ethernet Cable that can be used to extend any network beyond its physical boundaries. People love EXTNGO, they call it “Great things always come in small packages”. EXTNGO has proven to be useful in Car Diagnoses services, Hospitals, Schools, Digital Audio / Video production studios, and every single house in the united states that needs a simple and easy temporary network setup in their back yard, basement or any gaming area that needs reliable network connection. EXTNGO is a onetime investment for a life time problem. With EXTNGO, you will setup your temporary network swiftly and you will be able to retract the cable, store it nice and neatly. EXTNGO is all about being ready to deploy a network fast, and remove the cables even faster after the gig has finished.
EXTNGO comes in two color coded versions, the Orange is 50 Feet and the Green is 33 Feet. To eliminate any cable length doubts.
EXTNGO available on AMAZON.com only, you will not find it in your local market.
http://amzn.to/2wT4YHK
EMO Hannover 2013 has proven its role as the worlds leading trade fair for the metalworking industry. Over a busy six-day period, a total of 145.000 visitors came to the fair to learn about the latest trends and developments in the machine tools industry at a showcase dedicated to “Intelligence in Production.”
Leading scientists have released the latest results of the large scale trials related to nuts consumption and health, particularly in myocardial infarction, stroke and cardiovascular diseases. Recent scientific studies show the benefits of regular intake of nuts, not only associated with cardiovascular health but also with renal function, diabetes, cognitive function, atherosclerosis, metabolic syndrome, inflammatory biomarkers, etc. It is important to highlight that scientific evidence demonstrates that eating nuts is not associated with a higher risk of weight gain, and even reinforce their importance as sources of key nutrients.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62432-scientifically-proven-nuts-are-not-fattening
Today, Brother International Corporation, the leader in laser printing in the small office, home office market, announced its newest line of monochrome laser printers and all-in-ones. From work-from-home-warriors and small-office-heroes to trusted school administrators and busy medical practices, Brother has a proven track record of providing the most reliable printer solutions on the market, and today the best got even better.
The new lineup includes five printers and four all-in-ones to address the evolving needs of the busy home or small office, including the first Brother XL Extended Print laser models that include up to two years of toner in the box. Printers in the new lineup offer fastest-in-class print speeds, high-quality prints, and superb reliability, all while keeping budget in mind.
To view the multimedia release go to:
https://www.multivu.com/players/English/8253851-brother-monochrome-laser-printers-all-in-one/
In a major advancement for green technology, the TCO Certified eco-label for electronics, together with display industry leader NEC, today announced the NEC MultiSync® EA222WMe computer monitor as the first to receive the TCO Certified Edge award for groundbreaking achievements in environmental design. The award is presented in recognition of NEC’s achievement in eliminating halogens, a proven hazard to human health and the environment.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/tcodevelopment/44213/
On September 15th, Crest and Oral-B announced the kick off of National Gingivitis Awareness Month, with a press conference in Greeley Square Park, Manhattan, featuring “White Collar” star, Tiffani Thiessen. Thiessen is helping Crest and Oral-B to bring attention to the early gum disease, gingivitis, which affects more than fifty percent of American adults¹. Along with the declaration, Crest and Oral-B are helping consumers prevent and reverse gingivitis by introducing a new member to the Crest® Pro-Health® family, Crest® Pro-Health® Clinical Gum Protection. The new, advanced formula of Clinical Gum Protection provides Crest’s highest level of protection against the plaque bacteria that can cause gingivitis and with regular use, is clinically proven to help reverse gingivitis in just four weeks.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/crestprohealth/44592/
Nu Skin’s (NYSE: NUS) revolutionary anti-aging product lineup — ageLOC Transformation daily skin care, including ageLOC Future Serum — is used by more than 50,000 people every day to enjoy a more youthful appearance. The new skin care products were launched in 2010 and are clinically proven to reveal a more youthful appearance in eight key areas beginning after just seven days of use.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/nuskin/42697/
Nationally recognized fitness expert Andrea Metcalf of Chicago is showing you how to take it off with her new book, Naked Fitness, A 28 Day Proven Weight Loss Program for a Slimmer, Fitter, Pain-free body, (Vanguard Press) this spring by helping you take the first step: motivation, walking and rewards.
Don’t worry; you won’t have to strip off your clothes…only your fear of looking in the mirror. Metcalf’s plan inspires you to transform body and mind with personalized workouts, meals, beauty consultations, product demonstrations and more. But, if the thought of trying on a bathing suit still isn’t enough motivation to get you off the couch and moving, you’re not alone.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/nakedfitness/49063/
Bayer HealthCare’s Consumer Care division announced today the introduction of Bayer® Advanced Aspirin, the next generation of aspirin for pain relief. Using the patent-pending Pro-Release™ Technology, Bayer Advanced Aspirin is clinically proven to relieve tough pain twice as fast as previous Bayer® Aspirin tablets.
With the introduction of aspirin in 1899, Bayer offered one of the first widely accessible analgesics, or pain relievers, to consumers. Today, Bayer's overall global Aspirin business continues to grow, and had double-digit, year-on-year sales growth in Q1 2011. Yet, while Bayer continues to be a leader in the category, for many U.S. consumers, Bayer Aspirin is primarily synonymous with cardiovascular use. Now, through a combination of technological innovation and rich analgesic heritage, Bayer is introducing a new standard in aspirin for tough pain relief with Bayer Advanced Aspirin.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bayer/50414/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and is beginning to emerge in the community among people previously at low risk for the disease. In the largest Phase 3 clinical studies ever conducted in CDAD, DIFICID had clinical response rates at the end of treatment that were non-inferior to oral vancomycin. DIFICID was superior to vancomycin in sustaining clinical response through 25 days beyond the end of treatment. DIFICID is the only FDA-approved antibacterial drug proven to be superior to vancomycin in sustained clinical response for CDAD.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/optimerpharma/50177/
